Neurology Medical News about Neuroprotective effects

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Neuroprotective effects of the complement terminal pathway during demyelination: Implications for oligodendrocyte survival
Journal of Neuroimmunology, 07/10/09

Tegla CA et al. - Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system that is mediated by activated lymphocytes, macrophages/microglia, and complement. In MS, the myelin-forming oligodendrocytes (OLGs) are the targets of the immune attack. The findings indicate that the activation of complement and C5b-9 assembly can also have protective roles during demyelination.

<< Previous
Diagnostic and therapeutic pitfalls in neurosarcoidosis

Next >>
Catatonia Is not Schizophrenia: Kraepelin's Error and the Need to...

Potential Mechanisms Involved in the Prevention of Neurodegenerative Diseases by Lithium
CNS Neuroscience & Therapeutics, 11/11/09 Relevance Score: 66%

Neuroprotective Effects of Onion Extract and Quercetin Against Ischemic Neuronal Damage in the Gerbil Hippocampus
Journal of Medicinal Food, 10/28/09 Relevance Score: 64%

Review: antenatal magnesium sulphate prevents cerebral palsy in preterm infants
Evidence-Based Medicine, 10/26/09 Relevance Score: 64%

Promising Novel Treatment For Human Cancer Chrysanthemum Indicum Extract
ScienceDaily, 10/19/09 Relevance Score: 64%

Evaluating a Simple Method of Neuroprotective Hypothermia for Newborn Infants
Journal of Tropical Pediatrics, 10/01/09 Relevance Score: 64%